Page last updated: 2024-10-18

glycine and Dyspnea

glycine has been researched along with Dyspnea in 2 studies

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
" Mean absolute oral bioavailability ranged from 13·9% (fed) to 34·8% (fasting) in 12 patients treated at the 560 mg b."2.78Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromes. ( Komrokji, RS; Lancet, JE; List, AF; Maniar, M; Raza, A; Ren, C; Taft, D; Wilhelm, F, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komrokji, RS1
Raza, A1
Lancet, JE1
Ren, C1
Taft, D1
Maniar, M1
Wilhelm, F1
List, AF1
Bellomo, G1
Frigerio, G1
Giudice, S1
Mazzoni, P1

Trials

2 trials available for glycine and Dyspnea

ArticleYear
Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromes.
    British journal of haematology, 2013, Volume: 162, Issue:4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Biological Availability; Capsules; Disease Progressio

2013
Probit analysis of clinical data as a means for comparing antibiotic efficacies.
    Chemotherapy, 1970, Volume: 15, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Bronchitis; Child; Chloramphenicol; Clinical Trials as Topic; Dys

1970